Summary Aquestive Therapeutics (Aquestive) formerly known as Monosol Rx, is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations.The company offers PharmFilm, a drug delivery platform that delivers existing prescription products directly to the bloodstream.
Its products include zuplenz, suboxone, rizatriptan, diazepam, meloxicam, clobazam, colchicine, flu vaccine, and others.Aquestive also provides nutraceutical and various consumer products, packaging solutions, and drug products for the treatment of opioid dependence, nausea and vomiting.
The company partners with other pharmaceutical companies for the development and commercialization of pharmaceutical products.It has manufacturing facility located in Portage, Indiana, the US.
Aquestive is headquartered in Warren, New Jersey, the US.
Aquestive Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
The global blister packaging market reached a value of US$ 21.3 Billion in 2020. Blister packaging refers to a pre-formed plastic packaging which comprises of a cavity that is made using a thermoformed plastic and a paper or aluminum foil back. This type of packaging displays a large part of the content to consumers while protecting it from...
200 pages •
By The Business Research Company
• Mar 2021
Major players in the contract development manufacturing organizations market are Recipharm AB., Patheon Inc., Boehringer Ingelheim International, Catalent Inc., Lonza Group Ltd., Thermo Fisher Scientific Inc., Aenova Holding, Almac Group, Vetter, and Covance Inc. The global contract development manufacturing organizations market is...
190 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Potassium Citrate Market to Reach $795.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Potassium Citrate estimated at US$676.5 Million in the year 2020, is projected to reach a revised size of US$795.8 Million by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027....
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Propanol (Isopropanol and N-Propanol) Market to Reach 3.7 Thousand Kilo Tons by 2027
- Amid the COVID-19 crisis, the global market for Propanol (Isopropanol and N-Propanol) estimated at 2.8 Thousand Kilo Tons in the year 2020, is projected to reach a revised size of 3.7 Thousand Kilo Tons by 2027,...
133 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Cell Proliferation Kits Market to Reach $481.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Cell Proliferation Kits estimated at US$340.9 Million in the year 2020, is projected to reach a revised size of US$481.9 Million by 2027, growing at a CAGR of 5.1% over the analysis period...
140 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Chiral Chromatography Column Market to Reach $117.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Chiral Chromatography Column estimated at US$83.1 Million in the year 2020, is projected to reach a revised size of US$117.9 Million by 2027, growing at a CAGR of 5.1% over the analysis...
187 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Laboratory Disposables Market to Reach $20.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Laboratory Disposables estimated at US$13.8 Billion in the year 2020, is projected to reach a revised size of US$20.8 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027....
149 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Protein Hydrolysis Enzymes Market to Reach $3.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Protein Hydrolysis Enzymes estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 4.9% over the analysis period...
Beverage
Pharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.